Out-licensing: Pharmaceutical/Generics & Respiratory

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Open Innovation for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Partneringtools; Reports; Partnering Consulting; Due Diligence; Comparison
Due Diligence: Overview; Top Applications; Online Panel Discussions; Request Consultation
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs; Forums
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing Ltd
is a division of

Up-to-date access to technology licensing opportunities worldwide.

Displaying 1..4 of 4 - per page
Order by

New Active Ingredient + Innovative Drug Delivery System = Business Success More

A liquid system which enables rapid transmigration of therapeutic doses of up to large molecules More

Coupling drug substances with hydroxyethyl starch (HES) derivatives to improve pharmacokinetics and pharmacodynamics. More

Opioid receptor antagonist reducing opioid induced respiratory depression More

Displaying 1..4 of 4 - per page
Order by

Therapeutic target: Adult respiratory distress syndrome; Allergy, respiratory; Asthma; Asthma, bronchospasm; Bronchitis; Chest disorder (other); Chlamydia pneumoniae; Chronic obstructive pulmonary disease; Cough; Cystic fibrosis; Dysplasia, bronchopulmonary; Emphysema; Granulomatous lung disease sarcoidosis; Idiopathic respiratory distress syndrome; Meconium aspiration syndrome; Nasal disorder (other); Obstructive airway disease; Pneumonia; Pneumonocystis carinii lung infection; Pseudomonas lung infection; Respiratory disorder (other); Respiratory syncytial virus; Respiratory tract infections; Rhinitis; Rhinovirus (common cold); Sinusitis; Sleep apnea; Throat disorder (other); Tuberculosis
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Industry news: Pharmalicensing provides comprehensive industry coverage.